Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M87,414Revenue (TTM) $M16,551Net Margin (%)33.9Altman Z-Score10.9
Enterprise Value $M89,185EPS (TTM) $2.2Operating Margin %43.3Piotroski F-Score5
P/E(ttm)16.7Beneish M-Score-2.8Pre-tax Margin (%)42.8Higher ROA y-yN
Price/Book14.110-y EBITDA Growth Rate %19.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %17.3Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow15.8y-y EBITDA Growth Rate %11.6ROA % (ttm)42.4Higher Current Ratio y-yN
Dividend Yield %3.1PEG1.0ROE % (ttm)88.8Less Shares Outstanding y-yY
Payout Ratio %62.0Shares Outstanding M2,550ROIC % (ttm)143Gross Margin Increase y-yN

Gurus Latest Trades with NVO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NVO is held by these investors:

NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    Novo Nordisk Invites the Community to Unmask Everyday Heroes in Recognition of World Hemophilia Day Apr 17 2017 
    INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Law Mar 08 2017 
    NVO Lead Plaintiff Deadline Reminder: Hagens Berman Reminds Novo Nordisk Investors of March 13, 2017 Mar 06 2017 
    DEADLINE ALERT: Brower Piven Reminds Investors Of The March 13, 2017 Deadline In Class Action Lawsui Mar 05 2017 
    New Features: Individual Portfolio Tracker and Value Screens Tracker Mar 03 2017 
    NVO DEADLINE NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important March 13 Deadlin Mar 02 2017 
    While Big Diabetes Stagnates, Smaller Companies Are Moving Faster Than Ever Feb 09 2017 
    NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving No Feb 08 2017 
    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordis Feb 07 2017 

    More From Other Websites
    3 Beaten-Up Healthcare Stocks: Are They Bargains? Apr 19 2017
    Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Definitive Ratings to Nine CMBS... Apr 18 2017
    High-Yield Healthcare Investments You Can Buy Right Now Apr 18 2017
    Novo Nordisk Invites the Community to Unmask Everyday Heroes in Recognition of World Hemophilia Day Apr 17 2017
    Novo Nordisk A/S : NVO-US: Dividend Analysis : March 27th, 2017 (record date) : By the numbers :... Apr 10 2017
    5 Pharmaceutical Stocks With the Most Reliable Dividends Apr 09 2017
    [$$] The Charms of Bayer and Novo Nordisk Apr 07 2017
    Ailing Novo Seeks Cure With Diabetes Drug Targeting Fat Too Apr 06 2017
    Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 March 2017) Apr 03 2017
    Understanding Sanofi’s Valuation Compared to Peers Mar 31 2017
    Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results Mar 29 2017
    Novo Nordisk: Positive CHMP Nod for Tresiba Label Expansion Mar 28 2017
    GlaxoSmithKline’s Valuation Compared to Its Peers Mar 28 2017
    Citigroup Commercial Mortgage Trust 2017-P7 -- Moody's Assigns Provisional Ratings to Nine CMBS... Mar 27 2017
    New fast-acting mealtime insulin, Fiasp®, now approved and available in Canada for the treatment of... Mar 27 2017
    3 Tremendously Promising Diabetes Drugs Potentially on the Way Mar 26 2017
    Keller Rohrback L.L.P. Files Class-Action Lawsuit Over the Inflated Price of Insulin Mar 25 2017
    Novo’s Basal Insulin Gets CHMP Nod to Update Label Mar 24 2017
    Novo Nordisk’s Hemophilia B Drug Gets CHMP Nod Mar 24 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)